Biocon Merges Biologics Unit, Plans Rs 4,500 Cr Fundraise
Biocon announces merger of its biologics subsidiary with the parent company and a major Rs 4,500 crore fundraise. Explore the strategic shift and its impact on India's biotech sector.
Biocon announces merger of its biologics subsidiary with the parent company and a major Rs 4,500 crore fundraise. Explore the strategic shift and its impact on India's biotech sector.
A TADA court in Srinagar deals a blow to CBI, releasing an accused in the high-profile 1989 Rubaiya Sayeed kidnapping case by rejecting the agency's remand plea. Read the full details.
Toronto Maple Leafs defenseman Brandon Carlo suffers a major setback, returning to Toronto for tests. His indefinite absence deepens the team's blue-line concerns. Read more.
In a major political shift, MNS Kalyan District President Prakash Bhoir, along with two ex-corporators and hundreds of supporters, has joined the BJP. This move reshapes Dombivli's political landscape ahead of local body elections. Read more.
Odisha's Science Dept invites faculty & researchers for biotech R&D grants up to Rs 30 lakh. Maximum 10 projects selected yearly. Submit applications before December 10 deadline.
Fugitive Sandesara brothers offer Rs 5,100 crore settlement, bringing total recovery to Rs 9,800 crore - far exceeding banks' Rs 6,700 crore demand. ED celebrates biggest PMLA recovery.
Supreme Court permits Sandesara brothers to settle massive bank fraud case with ₹5,100 crore payment. Historic decision marks first criminal case closure after settlement. Read full details.
Karnataka government PU colleges face poor MBBS admission results despite online coaching initiatives for NEET, JEE, and KCET exams. Discover the challenges and state response.
Supreme Court approves ₹5,100 crore settlement by fugitive Sandesara brothers in massive bank fraud case. All criminal proceedings to be dropped upon payment completion by December 2025.
Supreme Court agrees to drop criminal proceedings against Sterling Biotech promoters in bank fraud case upon payment of Rs 5,100 crore by December 17, 2025. Full case details inside.
Congress party slams US panel report claiming Pakistan success against terrorism as severe setback to India's diplomatic efforts. Read full analysis of implications.
US Congress passes bill demanding full Epstein files release with overwhelming GOP support, dealing major political blow to President Trump. What's next?
India's biotechnology sector is projected to become a $1.2 trillion industry by 2047, driven by vaccines, diagnostics, and bio-agriculture. Discover how this growth will transform healthcare and agriculture.
A US commission warns Congress of China's growing leverage in biotech, quantum computing, and legacy semiconductors, urging action to prevent supply chain weaponization. Read the full report.
RJD acknowledges Bihar election setback, calls political fluctuations natural. Party remains committed to social justice amid NDA's landslide victory. Analysis inside.
Shashi Tharoor discloses he wasn't invited to campaign in Bihar elections, analyzes Congress party's setback. Read his full assessment of the 2025 polls.
Seemanchal region witnesses historic 73.2% voter turnout in Phase 2 elections. AIMIM faces virtual decimation while Congress, RJD gain significant ground. Political analysts reveal key factors behind polling surge.
In a stunning political upset, Democrats secure Alabama State Senate seat in Republican stronghold, marking first electoral defeat for Trump-backed candidates since his presidential announcement.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
TTV Dhinakaran slams AIADMK leadership for removing K.A. Sengottaiyan from the party, predicting severe political consequences in upcoming elections.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
Australian speedster Tayla Vlaeminck faces another heartbreaking setback as she's ruled out of the entire WBBL season due to persistent injury concerns, dealing a major blow to her team's campaign.
In a significant legal blow to fugitive diamantaire Mehul Choksi, a Belgian court has rejected his defence arguments as irrelevant to his extradition case, dealing a major setback to his attempts to avoid facing Indian authorities.
In a dramatic turn of events, Bhojpuri actress Seema Singh faces nomination rejection in Bihar polls, creating significant hurdles for NDA's election strategy and coalition dynamics.